Market Overview

Piper's Gene Munster Highlights iPhone 7 Inventory As 'Constrained'

Share:
Piper's Gene Munster Highlights iPhone 7 Inventory As 'Constrained'

Shares of Apple Inc. (NASDAQ: AAPL) sold off Friday following a report by a market research firm GfK which found that iPhone 7 and iPhone 7 Plus sales were 25 percent lower in its weekend launch compared to the prior model's launch.

GfK's report included data from 12 European countries and a handful of Asian countries, including China, but did not include any domestic data.

On Monday, Gene Munster of Piper Jaffray provided a first glimpse into U.S. selling trends. The analyst suggested that iPhone 7 available checks at 134 Apple stores showed a "constrained" inventory.

Related Link: Bank Of America Highlights 4 Flaws In Disappointing Apple iPhone 7 Data

Munster, one of the Street's most respected Apple analyst, added that his findings is a positive and bullish sign for Apple's stock as iPhone 7 sales are expected to be higher by a mid-teen percentage point year-over-year.

Munster also suggested that his findings are in-line with the company's own commentary about sellouts prior to the official launch.

Shares of Apple were trading higher by 0.27 percent at $113.01 late Monday morning.

Latest Ratings for AAPL

DateFirmActionFromTo
Dec 2019MaintainsOutperform
Dec 2019Initiates Coverage OnBuy
Dec 2019MaintainsOverweight

View More Analyst Ratings for AAPL
View the Latest Analyst Ratings

Posted-In: Gene Munster iPhone 7 Plus Sales iPhone 7 Sales Piper JaffrayAnalyst Color Analyst Ratings Tech Best of Benzinga

 

Related Articles (AAPL)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
SRPTPiperJaffrayMaintains210.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

6 Notable Stocks Trading Ex-Dividend Tuesday, September 27

vTv Therapeutics Shares Initiated With Buy Rating, $13 Target